QSI — Quantum-Si incorporated
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 149
- Website: https://www.quantum-si.com
Latest SEC filings for QSI
- 8-K — 2026-10-15
- 8-K — 2026-10-08
- 8-K — 2026-09-29
- SCHEDULE 13D/A — 2026-08-28
- 8-K — 2026-08-13
- 10-Q — 2026-08-13
- 8-K — 2026-07-24
- 8-K — 2026-06-24
- 8-K — 2026-05-15
- 10-Q — 2026-05-07
Latest QSI news
- — Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire Inc.)
- — Quantum-Si regains Nasdaq minimum bid price compliance (seekingalpha_market)
- — Leading Indicators For The October Breakout Cycle
- — Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
- — 2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private
- — Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
- — Head to Head Survey: Quantum-Si (NASDAQ:QSI) versus Twist Bioscience (NASDAQ:TWST)
- — Neuralink Stock: How to Invest Before the IPO
- — 3 Biotech Stocks Put Traders Are Targeting Today
- — Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Educational tool only — not investment advice.